These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 19345001

  • 1. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention.
    Wild CP, Montesano R.
    Cancer Lett; 2009 Dec 01; 286(1):22-8. PubMed ID: 19345001
    [Abstract] [Full Text] [Related]

  • 2. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
    Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA.
    Mutat Res; 2008 Dec 01; 659(1-2):176-84. PubMed ID: 18346933
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
    Kuang SY, Lekawanvijit S, Maneekarn N, Thongsawat S, Brodovicz K, Nelson K, Groopman JD.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb 01; 14(2):380-4. PubMed ID: 15734961
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC, Umbach DM, Yu MC, London SJ, Zhang ZQ, Taylor JA.
    Cancer Epidemiol Biomarkers Prev; 2001 Jun 01; 10(6):617-25. PubMed ID: 11401911
    [Abstract] [Full Text] [Related]

  • 5. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov 01; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 6. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K, Chen JG, Cui Y, Gong YY, Turner PC, Villar S, Wild CP, Parkin DM, Hainaut P.
    Cancer Epidemiol Biomarkers Prev; 2009 May 01; 18(5):1638-43. PubMed ID: 19366907
    [Abstract] [Full Text] [Related]

  • 7. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
    Hussain SP, Schwank J, Staib F, Wang XW, Harris CC.
    Oncogene; 2007 Apr 02; 26(15):2166-76. PubMed ID: 17401425
    [Abstract] [Full Text] [Related]

  • 8. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD, Lesi OA, Mendy M, Szymañska K, Whittle H, Goedert JJ, Hainaut P, Montesano R.
    Oncogene; 2005 Sep 01; 24(38):5858-67. PubMed ID: 16007211
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
    Tharayil VS, Roberts LR.
    Minerva Gastroenterol Dietol; 2006 Dec 01; 52(4):387-406. PubMed ID: 17108869
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interactive effects of chemical carcinogens and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.
    Harris CC, Sun TT.
    Cancer Surv; 1986 Dec 01; 5(4):765-80. PubMed ID: 3040243
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impacts of chemicals on liver cancer risk.
    Wogan GN.
    Semin Cancer Biol; 2000 Jun 01; 10(3):201-10. PubMed ID: 10936069
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
    Nguyen VT, Law MG, Dore GJ.
    J Viral Hepat; 2009 Jul 01; 16(7):453-63. PubMed ID: 19302335
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.